The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults
Open accessAbstract
BACKGROUND: Acetylcholinesterase inhibitors, such as neostigmine, have traditionally been used for reversal of non-depolarizing neuromuscular blocking agents. However, these drugs have significant limitations, such as indirect mechanisms of reversal, limited and unpredictable efficacy, and undesirable autonomic responses. Sugammadex is a selective relaxant-binding agent specifically developed for rapid reversal of non-depolarizing neuromuscular blockade induced by rocuronium. Its potential clinical benefits include fast and predictable reversal of any degree of block, increased patient safety, reduced incidence of residual block on recovery, and more efficient use of healthcare resources. OBJECTIVES: The main objective of this review was to compare the efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade caused by non-depolarizing neuromuscular agents in adults. SEARCH METHODS: We searched the following databases on 2 May 2016: Cochrane Central Register of Controlled Trials (CENTRAL); MEDLINE (WebSPIRS Ovid SP), Embase (WebSPIRS Ovid SP), and the clinical trials registries www.controlled-trials.com, clinicaltrials.gov, and www.centerwatch.com. We re-ran the search on 10 May 2017. SELECTION CRITERIA: We included randomized controlled trials (RCTs) irrespective of publication status, date of publication, blinding status, outcomes published, or language. We included adults, classified as American Society of Anesthesiologists (ASA) I to IV, who received non-depolarizing neuromuscular blocking agents for an elective in-patient or day-case surgical procedure. We included all trials comparing sugammadex versus neostigmine that reported recovery times or adverse events. We included any dose of sugammadex and neostigmine and any time point of study drug administration. DATA COLLECTION AND ANALYSIS: Two review authors independently screened titles and abstracts to identify trials for eligibility, examined articles for eligibility, abstracted data, assessed the articles, and excluded obviously irrelevant reports. We resolved disagreements by discussion between review authors and further disagreements through consultation with the last review author. We assessed risk of bias in 10 methodological domains using the Cochrane risk of bias tool and examined risk of random error through trial sequential analysis. We used the principles of the GRADE approach to prepare an overall assessment of the quality of evidence. For our primary outcomes (recovery times to train-of-four ratio (TOFR) > 0.9), we presented data as mean differences (MDs) with 95 % confidence intervals (CIs), and for our secondary outcomes (risk of adverse events and risk of serious adverse events), we calculated risk ratios (RRs) with CIs. MAIN RESULTS: = 0%; 10 studies, n = 959; GRADE: low quality).Application of trial sequential analysis (TSA) indicates superiority of sugammadex for outcomes such as recovery time from T2 to TOFR > 0.9, adverse events, and overall signs of postoperative residual paralysis. AUTHORS' CONCLUSIONS: Review results suggest that in comparison with neostigmine, sugammadex can more rapidly reverse rocuronium-induced neuromuscular block regardless of the depth of the block. Sugammadex 2 mg/kg is 10.22 minutes (˜ 6.6 times) faster in reversing moderate neuromuscular blockade (T2) than neostigmine 0.05 mg/kg (GRADE: moderate quality), and sugammadex 4 mg/kg is 45.78 minutes (˜ 16.8 times) faster in reversing deep neuromuscular blockade (PTC 1 to 5) than neostigmine 0.07 mg/kg (GRADE: low quality). With an NNTB of 8 to avoid an adverse event, sugammadex appears to have a better safety profile than neostigmine. Patients receiving sugammadex had 40% fewer adverse events compared with those given neostigmine. Specifically, risks of bradycardia (RR 0.16, NNTB 14; GRADE: moderate quality), PONV (RR 0.52, NNTB 16; GRADE: low quality), and overall signs of postoperative residual paralysis (RR 0.40, NNTB 13; GRADE: moderate quality) were reduced. Both sugammadex and neostigmine were associated with serious adverse events in less than 1% of patients, and data showed no differences in risk of serious adverse events between groups (RR 0.54; GRADE: low quality).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Estimating the mean and variance from the median, range, and the size of a sample
Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,175
The Mini‐Mental State Examination: A Comprehensive Review
Tombaugh, T. N., & McIntyre, N. J. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb01992.x · Cited by 5,152
Interaction revisited: the difference between two estimates.
Altman, D. G., & Bland, J. M. (2003) · BMJ · doi:10.1136/bmj.326.7382.219 · Cited by 3,203
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis
Wetterslev, J., Thorlund, K., Brok, J., & Gluud, C. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.03.013 · Cited by 1,881
Chan, A.-W., Hróbjartsson, A., Haahr, M. T., Gøtzsche, P. C., & Altman, D. G. (2004) · JAMA · doi:10.1001/jama.291.20.2457 · Cited by 1,845
Estimating required information size by quantifying diversity in random-effects model meta-analyses
Wetterslev, J., Thorlund, K., Brok, J., & Gluud, C. (2009) · BMC Medical Research Methodology · doi:10.1186/1471-2288-9-86 · Cited by 938
Brok, J., Thorlund, K., Wetterslev, J., & Gluud, C. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyn188 · Cited by 917
Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
Thorlund, K., Devereaux, P. J., Wetterslev, J., Guyatt, G., Ioannidis, J. P. A., Thabane, L., Gluud, L.-L., Als-Nielsen, B., & Gluud, C. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyn179 · Cited by 833
BERG, H., VIBY‐MOGENSEN, J., ROED, J., MORTENSEN, C. R., ENGBÆK, J., SKOVGAARD, L. T., & KRINTEL, J. J. (1997) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1997.tb04851.x · Cited by 647
Residual Neuromuscular Blockade and Critical Respiratory Events in the Postanesthesia Care Unit
Murphy, G. S., Szokol, J. W., Marymont, J. H., Greenberg, S. B., Avram, M. J., & Vender, J. S. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31816d1268 · Cited by 628
Murphy, G. S., & Brull, S. J. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181da832d · Cited by 483
Overcoming the limitations of current meta-analysis of randomised controlled trials
Pogue, J., & Yusuf, S. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08461-4 · Cited by 428
Eriksson, L. I., Sundman, E., Olsson, R., Nilsson, L., Witt, H., Ekberg, O., & Kuylenstierna, R. (1997) · Anesthesiology · doi:10.1097/00000542-199711000-00005 · Cited by 424
Pogue, J. M., & Yusuf, S. (1997) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00051-2 · Cited by 415
Impact of Anesthesia Management Characteristics on Severe Morbidity and Mortality
Arbous, M. S., Meursing, A. E. E., van Kleef, J. W., de Lange, J. J., Spoormans, H. H. A. J. M., Touw, P., Werner, F. M., & Grobbee, D. E. (2005) · Anesthesiology · doi:10.1097/00000542-200502000-00005 · Cited by 388
Jones, R. K., Caldwell, J. E., Brull, S. J., & Soto, R. G. (2008) · Anesthesiology · doi:10.1097/aln.0b013e31818a3fee · Cited by 369
Sundman, E., Witt, H., Olsson, R., Ekberg, O., Kuylenstierna, R., & Eriksson, L. I. (2000) · Anesthesiology · doi:10.1097/00000542-200004000-00014 · Cited by 361
Martini, C. H., Boon, M., Bevers, R. F., Aarts, L. P., & Dahan, A. (2014) · British Journal of Anaesthesia · doi:10.1093/bja/aet377 · Cited by 261
Agrell, B., & Dehlin, O. (2012) · Age and Ageing · doi:10.1093/ageing/afs149 · Cited by 246
Blobner, M., Eriksson, L. I., Scholz, J., Motsch, J., Della Rocca, G., & Prins, M. E. (2010) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32833d56b7 · Cited by 233
Postoperative residual neuromuscular block: a survey of management
Baillard, C., Clec'h, C., Catineau, J., Salhi, F., Gehan, G., Cupa, M., & Samama, C. M. (2005) · British Journal of Anaesthesia · doi:10.1093/bja/aei240 · Cited by 226
Brueckmann, B., Sasaki, N., Grobara, P., Li, M. K., Woo, T., de Bie, J., Maktabi, M., Lee, J., Kwo, J., Pino, R., et al. (2015) · British Journal of Anaesthesia · doi:10.1093/bja/aev104 · Cited by 204
AGRELL, B., & DEHLIN, O. (1998) · Age and Ageing · doi:10.1093/ageing/27.3.399 · Cited by 197
de Boer, H. D., Driessen, J. J., Marcus, M. A. E., Kerkkamp, H., Heeringa, M., & Klimek, M. (2007) · Anesthesiology · doi:10.1097/01.anes.0000270722.95764.37 · Cited by 196
Bias in Meta-Analysis Due to Outcome Variable Selection Within Studies
Hutton, J. L., & Williamson, P. R. (2000) · Journal of the Royal Statistical Society Series C: Applied Statistics · doi:10.1111/1467-9876.00197 · Cited by 194
Tramèr, M. R., & Fuchs-Buder, T. (1999) · British Journal of Anaesthesia · doi:10.1093/bja/82.3.379 · Cited by 191
QUANTITATIVE ASSESSMENT OF RESIDUAL ANTIDEPOLARIZING BLOCK (PART I)
ALI, H. H., UTTING, J. E., & GRAY, T. C. (1971) · British Journal of Anaesthesia · doi:10.1093/bja/43.5.473 · Cited by 185
Postoperative Residual Neuromuscular Blockade Is Associated with Impaired Clinical Recovery
Murphy, G. S., Szokol, J. W., Avram, M. J., Greenberg, S. B., Shear, T. D., Vender, J. S., Gray, J., & Landry, E. (2013) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3182742e75 · Cited by 161
A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade
Gurumeta, A. A., Ripollés‐Melchor, J., Casans‐Francés, R., Espinosa, Á. V., Hurtado, E. M., Fernández, C., Ramírez, J. M., López‐Timoneda, F., Vecino, J. M. C., & Evidence Anaesthesia Review Group (2015) · Anaesthesia · doi:10.1111/anae.13277 · Cited by 151
Geldner, G., Niskanen, M., Laurila, P., Мизиков, В. М., Hübler, M., Beck, G. C., Rietbergen, H., & Nicolayenko, E. M. (2012) · Anaesthesia · doi:10.1111/j.1365-2044.2012.07197.x · Cited by 142
Abrishami, A., Ho, J., Wong, J., Yin, L., & Chung, F. F. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007362.pub2 · Cited by 125
Eikermann, M., Blobner, M., Groeben, H., Rex, C. S., Grote, T., user, M. N., Beiderlinden, M., & Peters, J. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000195233.80166.14 · Cited by 84
Pongrácz, A., Szatmári, S., Nemes, R., Fülesdi, B., & TASSONYI, E. (2013) · Anesthesiology · doi:10.1097/aln.0b013e318297ce95 · Cited by 83
Kaufhold, N., Schaller, S. J., Stäuble, C. G., Baumüller, E., Ulm, K., Blobner, M., & Fink, H. (2016) · British Journal of Anaesthesia · doi:10.1093/bja/aev437 · Cited by 71
Koyuncu, O., Turhanoğlu, S., Akkurt, Ç. Ö., Karcıoğlu, M., Özkan, M., Özer, C., Sessler, D. I., & Turan, A. (2014) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2014.08.010 · Cited by 54
Nemes, R., Fülesdi, B., Pongrácz, A., Asztalos, L., Szabó-Maák, Z., Lengyel, S., & TASSONYI, E. (2016) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000000585 · Cited by 53
Woo, T., Kim, K. S., Shim, Y. H., Kim, M. K., Yoon, S. M., Lim, Y. J., Yang, H. S., Phiri, P., & Chon, J. Y. (2013) · Korean Journal of Anesthesiology · doi:10.4097/kjae.2013.65.6.501 · Cited by 50
Štourač, P., Adamus, M., Seidlová, D., Pavlík, T., Janků, P., Křikava, I., Mrozek, Z., Procházka, M., Klučka, J., Štoudek, R., et al. (2016) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001197 · Cited by 45
Xin-min, W., Ørding, H., Liu, J., Vanacker, B. F., Yao, S., Dahl, V., Xiong, L., Claudius, C., Yue, Y., Huang, Y., et al. (2014) · BMC Anesthesiology · doi:10.1186/1471-2253-14-53 · Cited by 41
Cited by
Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting
Gan, T. J., Belani, K. G., Bergese, S., Chung, F., Diemunsch, P., Habib, A. S., Jin, Z., Kovac, A. L., Meyer, T. A., Urman, R. D., et al. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004833 · Cited by 1,295
Kheterpal, S., Vaughn, M. T., Dubovoy, T. Z., Shah, N. J., Bash, L. D., Colquhoun, D. A., Shanks, A. M., Mathis, M. R., Soto, R. G., Bardia, A., et al. (2020) · Anesthesiology · doi:10.1097/aln.0000000000003256 · Cited by 304
Metadata
- Authors
- Hristovska, A.-M., Duch, P., Allingstrup, M., & Afshari, A.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2017-08-14
- Volume
- 2017
- Issue
- 9
- Pages
- CD012763-CD012763
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2749176690
- Cited by
- 319
- References
- 42
- FWCI
- 35.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.